HomeInsightsStock Comparison

Aarey Drugs Pharmaceuticals Ltd vs Mercury Laboratories Ltd Stock Comparison

Aarey Drugs Pharmaceuticals Ltd vs Mercury Laboratories Ltd Stock Comparison

Last Updated on: Jul 05, 2025

Key Highlights

  • The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 70.72 as of 04 Jul 15:30.
  • The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 5.4 on March 2020 to 26.8 on March 2024 . This represents a CAGR of 37.77% over 5 yearsThe P/E Ratio of Mercury Laboratories Ltd changed from 10.4 on March 2020 to 17.7 on March 2024 . This represents a CAGR of 11.22% over 5 years.
  • The Market Cap of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 31.1 crore on March 2020 to ₹ 124.9 crore on March 2024 . This represents a CAGR of 32.06% over 5 yearsThe Market Cap of Mercury Laboratories Ltd changed from ₹ 33.72 crore on March 2020 to ₹ 99.85 crore on March 2024 . This represents a CAGR of 24.25% over 5 years.
  • The revenue of Aarey Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 115.64 crore as compare to the Dec '24 revenue of ₹ 134.47 crore. This represent the decline of -14% The revenue of Mercury Laboratories Ltd for the Mar '25 is ₹ 20.84 crore as compare to the Dec '24 revenue of ₹ 20.1 crore. This represent the growth of 3.68%.
  • The ebitda of Aarey Drugs & Pharmaceuticals Ltd for the Mar '25 is ₹ 2.69 crore as compare to the Dec '24 ebitda of ₹ 2.88 crore. This represent the decline of -6.6% The ebitda of Mercury Laboratories Ltd for the Mar '25 is ₹ 2.31 crore as compare to the Dec '24 ebitda of ₹ 2.51 crore. This represent the decline of -7.97%.
  • The net profit of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 0.72 crore to ₹ 0.47 crore over 8 quarters. This represents a CAGR of -19.21% The net profit of Mercury Laboratories Ltd changed from ₹ 1 crore to ₹ 1.11 crore over 8 quarters. This represents a CAGR of 5.36% .
  • The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Mercury Laboratories Ltd changed from 7.43 % on March 2020 to 7.43 % on March 2024 . This represents a CAGR of 0.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aarey Drugs & Pharmaceuticals Ltd

  • Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
  • In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company.
  • Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
  • The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

About Mercury Laboratories Ltd

  • Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962.
  • Subsequently, the Company converted into Private Limited Company & incorporated in February, 1982.
  • Later, it further converted into Limited Company in 1992 in Maharashtra.
  • The Company is engaged in the business of Pharmaceutical items, medicinal drugs and formulations.
  • It is a profit making and dividend paying public limited company.

Aarey Drugs & Pharmaceuticals Ltd News Hub

News

Aarey Drugs & Pharmaceuticals to table results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

23 May 2025 20:23

News

Aarey Drugs & Pharmaceuticals to declare Quarterly Results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

07 Feb 2025 15:41

News

Aarey Drugs & Pharmaceuticals schedules EGM

Aarey Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of th...

Read more

05 Dec 2024 17:27

News

Aarey Drugs & Pharmaceuticals anounces board meeting date

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

30 Nov 2024 14:47

News

Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

27 Nov 2024 09:36

News

Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

07 Nov 2024 14:25

Mercury Laboratories Ltd News Hub

News

Board of Mercury Laboratories recommends final dividend

Mercury Laboratories announced that the Board of Directors of the Company at its meeting h...

Read more

14 May 2025 17:14

News

Mercury Laboratories schedules AGM

Mercury Laboratories announced that the 44th Annual General Meeting(AGM) of the company wi...

Read more

14 May 2025 17:14

News

Mercury Laboratories to announce Quarterly Result

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 Ma...

Read more

08 May 2025 15:24

News

Mercury Laboratories to table results

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 12 Fe...

Read more

07 Feb 2025 10:22

News

Mercury Laboratories schedules board meeting

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 No...

Read more

07 Nov 2024 16:57

News

Mercury Laboratories schedules AGM

Mercury Laboratories announced that the 43th Annual General Meeting (AGM) of the company w...

Read more

25 Jul 2024 14:42

SWOT Analysis Of Aarey Drugs & Pharmaceuticals Ltd

Strength

0

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Mercury Laboratories Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Aarey Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Mercury Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aarey Drugs & Pharmaceuticals Ltd and Mercury Laboratories Ltd

Which company has a larger market capitalization, Aarey Drugs & Pharmaceuticals Ltd or Mercury Laboratories Ltd?

Market cap of Aarey Drugs & Pharmaceuticals Ltd is 200 Cr while Market cap of Mercury Laboratories Ltd is 103 Cr

What are the key factors driving the stock performance of Aarey Drugs & Pharmaceuticals Ltd and Mercury Laboratories Ltd?

The stock performance of Aarey Drugs & Pharmaceuticals Ltd and Mercury Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarey Drugs & Pharmaceuticals Ltd and Mercury Laboratories Ltd?

As of July 5, 2025, the Aarey Drugs & Pharmaceuticals Ltd stock price is INR ₹70.72. On the other hand, Mercury Laboratories Ltd stock price is INR ₹858.85.

How do dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Mercury Laboratories Ltd compare?

To compare the dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Mercury Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions